2028年までの北米ポイントオブケア分子診断市場予測 - 製品とサービス（アッセイとキット、機器、サービスとソフトウェア）、技術（PCR、等温核酸増幅技術（INAAT）別）による新型コロナウイルス感染症の影響と地域分析、およびその他のテクノロジー）、アプリケーション（感染症、腫瘍学、血液学、出生前検査、内分泌学、およびその他のアプリケーション）、エンドユーザー（病院および診療所、診断研究所、研究機関および学術機関など）

市場紹介

ポイントオブケア分子診断には、ポータブルデバイス、アッセイおよびアンプが含まれます;喉のぬぐい液、血液、血清、便などの人間のサンプル中の病気を検出および診断するために使用されるキット。分子診断は、集中型の研究室から分散型のポイントオブケア分子検査へと移行しつつあります。 POCT は、そのシンプルさ、利便性、迅速な所要時間、患者の転帰改善の可能性により、急速に注目を集めています。

さらに、消費者を必要とする特定のウイルス検出方法に対する需要が高まっています。タイムリーな感染制御にかかる時間が短縮されることで、予測期間中の市場の成長が促進されると予想されます。

米国は、北米のすべての国の中で最も新型コロナウイルス感染症の感染者数が多い国です。これは、この地域のさまざまな産業、サプライチェーン、流通チェーンに悪影響を及ぼしています。パンデミックの間、ライフサイエンス企業は生命を脅かす病気の治療のための新薬の開発に重点を移しました。さらに、迅速検査装置の需要も増加しており、北米のポイントオブケア分子診断市場の成長に重要な役割を果たしています。さらに、新型コロナウイルス感染症の継続的な蔓延により、ポイントオブケア分子診断キットの需要が高まっています。これらのキットの採用により、新製品の開発と発売が促進されます。 2021 年 3 月、Eurofins の Clinical Enterprise, Inc. は、EmpowerDX COVID-19 ホームコレクションキットの消費者直販 (DTC) バージョンについて、米国食品医薬品局 (FDA) から緊急使用許可 (EUA) を取得しました。同様に、2020 年 7 月、Eurofins USA の Clinical Diagnostics は、SARS-CoV-2 を検出するためのプール型 PCR 検査の利用可能性を発表しました。これにより、顧客の PCR 検査あたりのコストが大幅に削減されます。

市場の概要とダイナミクス

北米のポイントオブケア分子診断市場は、 2021 年の 8 億 6,090 万米ドルから、2028 年までに 21 億 1,010 万米ドルに達します。市場は、2021 年から 2028 年にかけて 13.7% の CAGR で成長すると推定されています。現在進行中の新型コロナウイルス感染症（COVID-19）のパンデミックは、新型コロナウイルスを検出するためのPOC分子診断キットのメーカーにとっても機会を生み出している。たとえば、世界的なヘルスケアおよび医療機器メーカーである ABBOTT は、ID NOW を立ち上げました。これは、新型コロナウイルス感染を 5 分以内に検出する分子ポイントオブケア機器です。 ID NOW は、感染症を定性的に検出するための、機器ベースの迅速な等温技術です。独自の等温核酸増幅製品とこのサービスは分子データを数秒で生成するため、医師は患者の診察中に証拠に基づいた治療法を決定できます。 ID NOW は食品医薬品局 (FDA) によって認証または承認されていません。 FDA により、緊急使用許可 (EUA) に基づいて認可された研究室および患者ケアの現場で使用することが承認されています。このようなイノベーションと製品開発は、予測期間中に北米のポイントオブケア分子診断市場の成長に有利な機会を提供すると予想されます。

主要な市場セグメント

製品とサービスの観点からサービス、アッセイおよびキットのセグメントは、2020 年の北米ポイントオブケア分子診断市場で最大のシェアを占めました。テクノロジーの観点からは、PCR セグメントが北米ポイントオブケア分子診断市場で最大のシェアを占めました。 2020 年の診断市場。アプリケーションの観点からは、感染症セグメントが 2020 年の北米ポイントオブケア分子診断市場で最大のシェアを占めました。エンドユーザーの観点からは、診断研究所セグメントが最大のシェアを占めました。 2020 年の北米ポイントオブケア分子診断市場。

主要な情報源と企業のリスト

北米のポイントオブケア分子診断市場に関するこのレポートを作成するために参照されたいくつかの主要な一次および二次情報源は、企業の Web サイト、年次報告書、財務報告書、政府文書などです。、統計データベースなど。レポートに記載されている主要企業は、bioMérieux SA、F. Hoffmann-La Roche Ltd.、Danaher Corporation、Enzo Biochem, Inc.、Abbott、binx health, Inc.、Meridian BioScience, Inc.、Biocartis、Quidel Corporation、およびBio-Rad Laboratories, Inc.

購入理由レポート

北米のポイントオブケア分子診断市場の状況を理解し、高い収益を保証できる市場セグメントを特定する
絶えず変化する市場環境を理解し、競争で優位に立つため
北部における合併・買収および提携取引を効率的に計画するため最も売上が見込まれるセグメントを特定することにより、アメリカのポイントオブケア分子診断市場を分析する
さまざまなセグメントの市場パフォーマンスの知覚的かつ包括的な分析から、知識に基づいたビジネス上の意思決定を行う
2021 年から 2028 年のさまざまなセグメントに基づいて、北米のポイントオブケア分子診断市場の市場収益予測を取得します

北米ポイントオブケア分子診断市場セグメンテーション

製品別 ;サービス

アッセイとキット
機器
サービスとソフトウェア

技術別

PCR
等温核酸増幅技術 (INAAT)
その他のテクノロジー

作成者アプリケーション

作成者エンドユーザー

病院および診療所
診断検査機関
研究機関および学術機関
その他

国別

北米
- 米国
- カナダ
- メキシコ

記載されている企業

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Point-of-Care Molecular Diagnostics Market – By Product & Services

1.3.2 North America Point-of-Care Molecular Diagnostics Market – By Technology

1.3.3 North America Point-of-Care Molecular Diagnostics Market – By Application

1.3.4 North America Point-of-Care Molecular Diagnostics Market – By End User

1.3.5 North America Point-of-Care Molecular Diagnostics Market– By Geography

2. North America Point-of-Care Molecular Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Point-of-Care Molecular Diagnostics Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.3 Experts Opinion

5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control

5.1.2 Rising Incidences of Infectious Diseases

5.2 Market Restraints

5.2.1 Pricing Pressures owing to Reimbursement Cuts

5.3 Market Opportunities

5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics

5.4 Future Trends

5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting

5.5 Impact Analysis

6. Point-of-Care Molecular Diagnostics Market– North America Analysis

6.1 North America Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis

7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services

7.1 Overview

7.2 Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

7.3 Assays and Kits

7.3.1 Overview

7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Services and Software

7.5.1 Overview

7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology

8.1 Overview

8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

8.3 PCR

8.3.1 Overview

8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1 Overview

8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Point-of-Care Molecular Diagnostics Market Analysis – By Application

9.1 Overview

9.2 Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

9.3 Infectious Disease

9.3.1 Overview

9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Oncology

9.4.1 Overview

9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Hematology

9.5.1 Overview

9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Prenatal Testing

9.6.1 Overview

9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.7 Endocrinology

9.7.1 Overview

9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.8 Others

9.8.1 Overview

9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User

10.1 Overview

10.2 Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Diagnostic Laboratories

10.4.1 Overview

10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Research and Academic Institutes

10.5.1 Overview

10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11. North America Point-of-Care Molecular Diagnostics Market – Geographic Analysis

11.1 North America: Point-of-Care Molecular Diagnostics Market

11.1.1 Overview

11.1.2 North America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

11.1.3 North America Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.4 North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.5 North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.6 North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7 North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

11.1.7.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.1 US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.2 US Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.3 US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.1.4 US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.7.1.5 US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.2 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.1 Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.2 Canada Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.3 Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.2.4 Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.7.2.5 Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.7.3 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.1 Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.2 Mexico Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.3 Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

11.1.7.3.4 Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

11.1.7.3.5 Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

13. Point-of-Care Molecular Diagnostics Market– Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 F. Hoffmann-La Roche Ltd.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 bioMérieux SA

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Abbott

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 MERIDIAN BIOSCIENCE, INC.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Enzo Biochem Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Biocartis

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Quidel Corporation

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Danaher

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 BIO-RAD LABORATORIES INC.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 binx health, inc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

Table 2. North America Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 3. North America Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 4. North America Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. US Point-of-Care Molecular Diagnostics Market, by Product & services – Revenue and Forecast to 2028 (USD Million)

Table 6. US Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 7. US Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 8. US Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Canada Point-of-Care Molecular Diagnostics Market, by Product & services -Revenue and Forecast to 2028 (USD Million)

Table 10. Canada Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 11. Canada Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 12. Canada Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Mexico Point-of-Care Molecular Diagnostics Market, by Product & services -Revenue and Forecast to 2028 (USD Million)

Table 14. Mexico Point-of-Care Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 15. Mexico Point-of-Care Molecular Diagnostics Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 16. Mexico Point-of-Care Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market

Table 18. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market

Table 19. Glossary of Terms, Point-of-Care Molecular Diagnostics Market

LIST OF FIGURES

Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation

Figure 2. North America Point-of-Care Molecular Diagnostics Market Overview

Figure 3. Assays and Kits Segment Held the Largest Share by Product & services in North America Point-of-Care Molecular Diagnostics Market

Figure 4. US to Show Significant Growth During Forecast Period

Figure 5. North America Point-of-Care Molecular Diagnostics Market, Industry Landscape

Figure 6. North America PEST Analysis

Figure 7. North America Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8. Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)

Figure 9. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)

Figure 13. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)

Figure 17. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)

Figure 24. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. North America: Point-of-Care Molecular Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 29. North America Point-of-Care Molecular Diagnostics Market Revenue and Forecast to 2028 (USD Million)

Figure 30. North America: Point-of-Care Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 31. US: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Canada: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. Mexico: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in North America

Figure 35. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Point-of-Care molecular diagnostics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the North America Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000